Full-Time

ERP Lead

Spectrum Vascular

Spectrum Vascular

11-50 employees

Produces vascular-access devices to reduce infections

No salary listed

Middlesex, NJ, USA

In Person

On-site role located in Warren, New Jersey.

Category
Operations & Logistics (1)
Required Skills
Middleware
NetSuite
SAP Products
.NET
REST APIs

Get referred to Spectrum Vascular

See people who can refer or advise you

Requirements
  • 10+ years of ERP implementation experience, with significant time in technical lead roles
  • Hands-on experience with at least one Tier-1 or Tier-2 ERP platform — QAD strongly preferred; alternatively SAP (ECC/S4), Oracle EBS/Fusion, Microsoft Dynamics 365 F&O, Infor (LN/M3/CSI), IFS, Epicor, or NetSuite in a manufacturing context
  • At least two end-to-end ERP implementations through go-live in a technical capacity, including at least one in a discrete or process manufacturing environment
  • Strong functional and technical depth in Manufacturing (Shop Floor, MRP, Routings, BOMs, Work Orders, Inventory) plus working knowledge of Finance, Distribution, and Procurement modules — on any major ERP
  • Cutover and hypercare leadership experience for a live ERP go-live in the last 5 years
  • Solid grasp of ERP integration patterns and tooling (APIs, middleware, EDI, reporting/BI). Familiarity with QAD's stack — Progress/OpenEdge, .NET UI, QXtend, Boomi — is a plus; non-QAD candidates should demonstrate the ability to learn it quickly
  • Experience working with system integrators and multi-vendor delivery teams
  • Excellent stakeholder management; comfortable operating from shop floor to C-suite
Responsibilities
  • Take immediate technical ownership of the active delivery, including solution design, configuration decisions, and cutover readiness from current state through go-live
  • Lead the final stretch of UAT, data migration dry runs, cutover rehearsals, and go/no-go technical decisions
  • Work alongside the system integrator (SI) and internal team to hold technical timelines, scope, and quality
  • Own hypercare post go-live: defect triage, P1/P2 resolution, business stabilization, and transition to steady-state support
  • Define and lead the technical roadmap for the next delivery wave, covering Manufacturing modules (Shop Floor Control, Work Orders, Routings, BOMs, MRP, Capacity Planning, Inventory) and carried-over backlog items
  • Own the solution architecture, design decisions, and technical resource model for the next wave
  • Lead requirements workshops with manufacturing, planning, supply chain, and finance stakeholders; sign off on solution design, gaps, and customizations
  • Drive build, configuration, integration (MES, WMS, finance, EDI as applicable), testing cycles (SIT, UAT, performance), data migration, training, and cutover
  • Lead go-live readiness reviews and hypercare through stabilization
  • Single point of technical accountability to the program sponsor and steering committee for ERP delivery
  • Provide technical direction to SI partners, internal functional consultants, developers, and business SMEs
  • Own program-level technical risks, dependencies, and change requests
  • Establish and enforce delivery standards: design documentation, test evidence, cutover playbooks, and post-go-live technical KPIs
  • Coach and mentor internal team to build long-term ERP capability
Desired Qualifications
  • Prior QAD exposure, or experience transitioning from another ERP into QAD
  • Technical or functional certifications in QAD, SAP, Oracle, or Microsoft Dynamics across Financials, Manufacturing, or Supply Chain
  • Experience in regulated industries (automotive, life sciences, medical devices, food & beverage, industrial)
  • Exposure to integrations with MES, WMS, Salesforce, or major EDI partners
  • Experience with ERP upgrades or on-premise to cloud migrations

Spectrum Vascular makes vascular access and medication management devices. Its products include central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, and intraosseous needles designed to reduce infections and thrombus formation, with antimicrobial protection features like SV Spectrum and SV BioFlo. The company built its portfolio by acquiring Cook Medical’s vascular access lines in 2023 and AngioDynamics’ PICCs, midlines, and tip-location products in 2024, creating a broad platform for care across settings. Backed by private investors, Spectrum Vascular plans to grow through strategic leadership and expansion, aiming to lower infection risk and complications for patients and caregivers.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

White Plains, New York

Founded

N/A

Get referred to Spectrum Vascular

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 Piccolo acquisition broadens guidance sales and cross-sell into Spectrum's catheter base.
  • Spectrum's 2025 SK Capital recapitalization funds expansion and commercialization under Ken Miller.
  • January 2025 Piccolo distribution already seeded hospital relationships before the June 2026 buyout.

What critics are saying

  • FDA posted a March 2026 Class 2 recall for Spectrum Central Venous Tray expiration labeling.
  • Cook-owned legacy products still carry recall risk, exposing Spectrum's inherited quality systems.
  • BD launched CentroVena One in April 2026, compressing Spectrum's differentiation window.

What makes Spectrum Vascular unique

  • SK Capital-backed Spectrum unites Cook, AngioDynamics, and Piccolo vascular access portfolios by June 2026.
  • Piccolo's 510(k)-cleared blood-flow sensing navigation eliminates confirmatory chest X-rays.
  • Ken Miller and Doug Shook bring KORU, ICU Medical, and BD vascular access expertise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Stock Options

Company Equity

Wellness Program

Mental Health Support

Conference Attendance Budget

Professional Development Budget

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

29%

1 year growth

29%

2 year growth

29%
PR Newswire
Jun 11th, 2026
Spectrum Vascular acquires Piccolo Medical to advance real-time catheter navigation technology

Spectrum Vascular has acquired Piccolo Medical, a developer of catheter guidance technology, to accelerate commercialisation of next-generation vascular access solutions. Piccolo CEO Augustus Shanahan will join Spectrum alongside his team to advance the company's 510(k)-cleared catheter guidance products. Piccolo's technology uses proprietary blood flow sensing to guide catheter tip placement in real time, eliminating the need for confirmatory chest X-rays. The company completed its first successful patient placements of the Nav+ Stylet in May 2026. Founded in 2016 and based in San Francisco, Piccolo was spun out of the Theranova medical device incubator. Spectrum Vascular, backed by SK Capital Partners, was formed through acquisitions of vascular access businesses from Cook Medical and AngioDynamics.

Cardiac Vascular News
Jun 11th, 2026
Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology.

Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology. More in financial: PR News WireThis post was originally published on this site WHITE PLAINS, N.Y., June 11, 2026 /PRNewswire/ - Spectrum Vascular ("Spectrum"), a leading provider of vascular access and medication management products, today announced the acquisition of Piccolo Medical ("Piccolo"), a developer of state-of-the-art catheter guidance products. The transaction deepens a partnership focused on bringing next-generation catheter guidance technology to market and marks a significant step forward in Spectrum's mission to deliver a complete, differentiated vascular access solution to the clinical community. Augustus Shanahan, CEO of Piccolo, will join Spectrum alongside the legacy Piccolo team. The group will advance development and commercialization of its 510(k)-cleared catheter guidance and location products, building upon an innovation roadmap more than a decade in the making. Piccolo's real-time catheter guidance utilizes proprietary blood flow sensing technology to precisely guide catheter tip placement, eliminating the need for confirmatory chest X-rays. Piccolo completed the first successful patient placements of its next-generation Nav+ Stylet in May 2026, marking the beginning of a new era in guided vascular access. "Joining the Spectrum team marks an exciting new chapter for Piccolo and for vascular access as a whole," said Augustus Shanahan. "I am incredibly proud of what the Piccolo team has built over the past decade, and together with Spectrum, we now have the platform, the portfolio, and the reach to set a new standard, delivering better outcomes for patients and real economic value for the hospitals that serve them." Kenneth Miller, CEO of Spectrum, commented, "The acquisition of Piccolo Medical represents an important milestone in our mission to transform vascular access. By combining Piccolo's breakthrough navigation technology with Spectrum's vascular access portfolio and commercial reach, we are uniquely positioned to accelerate innovation, improve patient care, and redefine the standard of care for clinicians worldwide." Together, Piccolo and Spectrum will accelerate commercialization, deepen integration with Spectrum's existing catheter portfolio, and scale the next-generation navigation platform. The combined organization is poised to set a new standard of care in vascular access with greater speed and reach. About Spectrum Vascular Spectrum Vascular, backed by SK Capital Partners, is a leading provider of vascular access and medication management products engineered to reduce healthcare-acquired infections. The Company's mission is to improve the lives of patients worldwide by providing caregivers with high quality, innovative products with exceptional customer service. Innovation has been a core strategic pillar throughout Spectrum's history and many of its products have been designed to deliver antimicrobial protection and thrombus reduction. Spectrum was formed through the acquisition of the vascular access businesses of Cook Medical and AngioDynamics. For more information, please visit www.spectrumvascular.com. About Piccolo Medical Piccolo Medical is a San Francisco-based medical device company and pioneer in catheter navigation and tip confirmation technology. Founded in 2016, Piccolo was spun out of the Theranova medical device incubator and has been funded through private investors as well as prestigious grant awards from The Eunice Kennedy Shriver National Institute of Child Health and Human Development. Piccolo is committed to developing and commercializing innovative vascular access technologies designed to improve clinical outcomes, streamline procedures, and reduce complications for patients. For more information, please visit www.piccolomedical.com. SOURCE Spectrum Vascular

FinSMEs
Mar 31st, 2025
Spectrum Vascular Gains SK Capital Investment

Spectrum Vascular, a NYC-based medical device company, received an undisclosed investment from SK Capital Partners. The funds will be used to expand operations and development efforts. Spectrum Vascular, founded in 2023, specializes in vascular access and medication management products and was formed through the acquisition of the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024.

BioSpace
Jan 13th, 2025
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular

SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ - Piccolo Medical(R), an emerging leader in catheter navigation devices for vascular access procedures, is proud to announce an exclusive distribution agreement with Spectrum Vascular(TM), a leading provider of vascular access and medication management products designed to reduce healthcare acquired infections ("HAI").